Bayer Files False Advertising Lawsuit Against Johnson & Johnson Over Cancer Drug

New York, Sunday, 1 March 2026.
Bayer alleges Johnson & Johnson utilized false advertising to undermine its rival prostate cancer drug, Nubeqa, a legal battle emerging even as JNJ shares trade significantly above analyst price targets.